Pipeline dossier

NIH & clinical-trial pipeline signals for Medical Care Technologies Inc. (MDCE)

Leading indicators across the NIH grant → clinical trial → SEC filing chain for MDCE, mapped to public ticker MDCE (CIK 0001404593). Sourced live from public data.

⚠ Research/informational signals from public data (NIH · ClinicalTrials.gov · SEC EDGAR). Not investment advice. Full scope →

Trial → FilingMDCE35% conf

Medical Care Technologies Inc. (MDCE) — PHASE3 protocol updated 1 days ago

Upstream (observed)
Clinical trial status (PHASE3) — Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

↓ Phase-transition base rate 57% (Wong/Siah/Lo 2019)

Predicted downstream
SEC 8-K / press release on NDA/BLA filing (FDA submission) (12-24 mo, base rate 57%)

trial ↗filings ↗

Recent SEC 8-K filings

2012-11-20 — 8-K 7.01,9.01 view ↗
2012-10-12 — 8-K 1.01,3.02,5.02,7.01,9.01 view ↗
2012-09-14 — 8-K 8.01 view ↗
2012-07-27 — 8-K 1.01,1.02,2.03,2.04,3.02,9.01 view ↗
2012-07-17 — 8-K 1.01,2.03,3.02,4.02,9.01 view ↗

JSON API for this entity →